Geron Corporation to Present at Lazard's Life Sciences Conference.MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN v. t. 1. To grin or yawn. ) will be presenting an update of the company's product development programs at the Lazard Life Sciences Conference in New York on Tuesday, November 30, 2004, at 8:00 a.m. Eastern Time. Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive officer, will be giving the presentation. The presentation will cover Geron's portfolio of telomerase-based anti-cancer therapies, including GRN GRN Green GRN Green (Political) Party GRN Global Recycling Network GRN Gulf Restoration Network (New Orleans, LA) GRN Goods Received Note GRN Global Reference Network (GPS) 163L and the telomerase telomerase /telo·mer·ase/ (te-lo´mer-as) a DNA polymerase involved in the formation of telomeres and the maintenance of telomere sequences during replication. te·lom·er·ase n. vaccine, as well as progress in its human embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. (hESC) programs for the treatment of spinal cord injury Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. , diabetes and heart disease. The audio and slide presentation will be available at the following web address: http://www.wsw.com/webcast/lz/gern. The webcast will be archived for 30 days. For further information, please contact Geron Corporation at 650-473-7765 or visit Geron's website at www.geron.com. Geron is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for cancer based on its telomerase technology, and cell-based therapeutics using its human embryonic stem cell technology. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion